ESMO

Pharma

Novartis, Daiichi, AZ shine in ESMO analysis of cancer approvals

Novartis, Daiichi Sankyo and AstraZeneca emerged as the top drugmakers in an analysis of the clinical value added by new solid tumor cancer medicines.

Kevin Dunleavy Sep 13, 2024 8:06am

ESMO: Padcev-Keytruda combo nearly doubles survival in key trial

Oct 22, 2023 10:17am

At ESMO, Merck touts Welireg's potential in kidney cancer

Oct 21, 2023 9:00am

ESMO: Searching for the perfect cup of pharma-branded espress-MO

Oct 20, 2023 7:59am